SCIENTURE HOLDINGS, INC. Cash Equivalents, at Carrying Value
SCIENTURE HOLDINGS, INC. (SCNX) had Cash Equivalents, at Carrying Value of $8.19 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-13
- 2026-06-30: Cash Equivalents, at Carrying Value $8.19M.
- 2026-03-31: Cash Equivalents, at Carrying Value $3.54M.
- 2025-12-31: Cash Equivalents, at Carrying Value $6.66M.
- 2024-12-31: Cash Equivalents, at Carrying Value $308.10K.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $8.19M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $3.54M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $6.66M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $308.10K 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |